FLASH SALE! 50% Off PremiumSubscription Claim Offer ⏰ 0d 00h 00m 00s

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.863 10 days ( 35.15 % )
Last Price $0.105 3.45 %
High/ Low $0.0956 - $0.108 -7.74%
Chg 7 Days -14.63 % $0.123 $0.105
Chg 30 Days -48.28 % $0.203 $0.105
Chg 12 mos -92.45 % $1.39 $0.105
Trend - 3 mos -55.59 % Width: 215.70 %
Trend - 12 mos -62.15 % Width: 498.84 %
Pred. range - 3 mos $0.0423 - $0.134 -59.72 % - 27.17 %
Pred. range - 12 mos $0.0370 - $0.221 -64.80 % - 110.80 %
Short MA avg 3 mos Sell Jan 03, 2025 - 11 days
Long MA avg 3 mos Sell Nov 20, 2024 - 40 days
Short/Long MA avg 3 mos Sell Nov 21, 2024 - 39 days
Short MA avg 12 mos Sell Jan 03, 2025 - 11 days
Long MA avg 12 mos Sell Aug 27, 2024 - 100 days
Short/Long MA avg 12 mos Sell Sep 12, 2024 - 89 days
Pivot Short Buy Jan 17, 2025 - 2 days
Bollinger Buy Nov 19, 2024 - 41 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT BIOLINERX LTD.
BioLineRx Ltd.
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...
GOLDEN STAR
Ticker Change Signal Date
H
HYLS
$41.55
0.289% Jan 15
ROIC
$17.41
0.230% Jan 15
V
VGSH
$58.23
0.0515% Jan 15
F
FALN
$26.87
0.447% Jan 15
F
FTSM
$59.87
0.0668% Jan 15

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE